BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10394843)

  • 41. Canine dermatophytosis caused by Trichophyton rubrum: an example of man-to-dog transmission.
    Van Rooij P; Declercq J; Beguin H
    Mycoses; 2012 Mar; 55(2):e15-7. PubMed ID: 21771108
    [No Abstract]   [Full Text] [Related]  

  • 42. What defines the quality of patient care in tinea pedis?
    Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experiences with tinea pedis in daily practice].
    Janke D
    Arch Klin Exp Dermatol; 1966; 227(1):564-8. PubMed ID: 4383352
    [No Abstract]   [Full Text] [Related]  

  • 44. Bullous tinea pedis in two children.
    Neri I; Piraccini BM; Guareschi E; Patrizi A
    Mycoses; 2004 Dec; 47(11-12):475-8. PubMed ID: 15601452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An epidemiological and clinical study of untreated patients with tinea pedis within a company in Japan.
    Maruyama R; Hiruma M; Yamauchi K; Teraguchi S; Yamaguchi H
    Mycoses; 2003 Jun; 46(5-6):208-12. PubMed ID: 12801364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Well-Demarcated, Scaly Plaques.
    Milam EC; Meehan SA; Ramachandran S
    JAMA; 2016 Feb; 315(5):508-9. PubMed ID: 26836734
    [No Abstract]   [Full Text] [Related]  

  • 47. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
    Kumar N; Shishu
    Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical treatment for moccasin-type tinea pedis.
    Greer DL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):554-8. PubMed ID: 3546420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-dermatophytic activity of bakuchiol: in vitro mechanistic studies and in vivo tinea pedis-inhibiting activity in a guinea pig model.
    Lau KM; Wong JH; Wu YO; Cheng L; Wong CW; To MH; Lau CP; Yew DT; Leung PC; Fung KP; Hui M; Ng TB; Lau CB
    Phytomedicine; 2014 Jun; 21(7):942-5. PubMed ID: 24703327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A nitric oxide-releasing solution as a potential treatment for fungi associated with tinea pedis.
    Regev-Shoshani G; Crowe A; Miller CC
    J Appl Microbiol; 2013 Feb; 114(2):536-44. PubMed ID: 23082864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mycosis caused by Trichophyton rubrum in the inguinal-femoral-scrotal area and methods of its treatment].
    Rudiak AL
    Vestn Dermatol Venerol; 1973 Jun; 47(6):71-3. PubMed ID: 4764164
    [No Abstract]   [Full Text] [Related]  

  • 52. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of 40% urea cream in the treatment of moccasin tinea pedis.
    Elewski BE; Haley HR; Robbins CM
    Cutis; 2004 May; 73(5):355-7. PubMed ID: 15186053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinico-mycologic analysis of the effectiveness of treatment in patients with rubrophytosis of the feet].
    Vashchuk ZhE; Svirid SG; MarakhovskiÄ­ AV
    Vrach Delo; 1989 Jan; (1):92-4. PubMed ID: 2718461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A three-stage clinical evaluation of etonam (R 10 100) in the treatment of chronic athlete's foot.
    Brugmans J; Van Cutsem J
    Dermatologica; 1969; 138(5):403-17. PubMed ID: 4946929
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of terbinafine and clotrimazole in treating tinea pedis.
    Evans EG; Dodman B; Williamson DM; Brown GJ; Bowen RG
    BMJ; 1993 Sep; 307(6905):645-7. PubMed ID: 8401048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect.
    Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
    Microbiol Immunol; 2002; 46(7):433-9. PubMed ID: 12222929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of Tinea Pedis in Elderly Patients Using External Preparations].
    Otani M
    Med Mycol J; 2017; 58(2):J35-J41. PubMed ID: 28566665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trials.
    Savin R; Atton AV; Bergstresser PR; Elewski B; Jones HE; Levine N; Leyden J; Monroe A; Pandya A; Shupack J
    J Am Acad Dermatol; 1994 Apr; 30(4):663-7. PubMed ID: 8157801
    [No Abstract]   [Full Text] [Related]  

  • 60. [The dermatophytic flora surveyed at the Dermatology Clinic of the Tottori University Hospital from 1981 to 1984--statistic analysis of the patients of various clinical types and a comparative study of the ratios of T. rubrum/T. mentagrophytes at dermatology clinics in Japan].
    Kawaguchi T
    Nihon Hifuka Gakkai Zasshi; 1986 Dec; 96(14):1627-38. PubMed ID: 2951537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.